tiprankstipranks
Advertisement
Advertisement
Actinium Highlights New ATNM-400 Data Amid Listing Pressure
PremiumCompany AnnouncementsActinium Highlights New ATNM-400 Data Amid Listing Pressure
1M ago
Actinium Pharmaceuticals receives two patent allowances from CIPO
Premium
The Fly
Actinium Pharmaceuticals receives two patent allowances from CIPO
1M ago
Analyst Reiterates Buy on Actinium, Keeps $4 Price Target Amid Advancing Radiotherapy Pipeline and 2026–2027 Catalysts
Premium
Ratings
Analyst Reiterates Buy on Actinium, Keeps $4 Price Target Amid Advancing Radiotherapy Pipeline and 2026–2027 Catalysts
2M ago
Is ATNM a Buy, Before Earnings?
PremiumPre-EarningsIs ATNM a Buy, Before Earnings?
4M ago
Promising Potential of Actinium Pharmaceuticals’ ATNM-400 Drives Buy Rating
Premium
Ratings
Promising Potential of Actinium Pharmaceuticals’ ATNM-400 Drives Buy Rating
7M ago
Actinium Pharmaceuticals: Promising Developments and Strong Financial Position Drive Buy Rating
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments and Strong Financial Position Drive Buy Rating
7M ago
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating
PremiumRatingsActinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating
7M ago
Actinium Pharmaceuticals: Promising Developments and Strong Financial Health Support Buy Rating
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments and Strong Financial Health Support Buy Rating
8M ago
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100